Easton Total Revenue from 2010 to 2026

Easton Pharmaceutica's Total Revenue is decreasing with very volatile movements from year to year. Total Revenue is predicted to flatten to 0.00. Total Revenue is the total amount of income generated by the sale of goods or services related to Easton Pharmaceutica's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2001-06-30
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
173.3 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Easton Pharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Easton Pharmaceutica's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 161.2 K or Research Development of 179.8 K, as well as many indicators such as Price To Sales Ratio of 0.94, Dividend Yield of 0.0 or PTB Ratio of 0.13. Easton financial statements analysis is a perfect complement when working with Easton Pharmaceutica Valuation or Volatility modules.
  
Build AI portfolio with Easton Stock
Check out the analysis of Easton Pharmaceutica Correlation against competitors.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
The Total Revenue trend for Easton Pharmaceutica offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Easton Pharmaceutica is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Easton Pharmaceutica's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Easton Pharmaceutica over the last few years. Total revenue comprises all receipts Easton Pharmaceutica generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Easton Pharmaceutica's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Easton Pharmaceutica's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Very volatile
   Total Revenue   
       Timeline  

Easton Total Revenue Regression Statistics

Arithmetic Mean146,975
Geometric Mean0.00
Coefficient Of Variation258.85
Mean Deviation211,677
Median0.00
Standard Deviation380,442
Sample Variance144.7B
Range1.6M
R-Value(0.04)
Mean Square Error154.1B
R-Squared0
Significance0.87
Slope(3,321)
Total Sum of Squares2.3T

Easton Total Revenue History

20191.6 M
2018378.6 K
2017153 K
201644 K
201467.4 K
2011null
2010300 K

About Easton Pharmaceutica Financial Statements

Investors use fundamental indicators, such as Easton Pharmaceutica's Total Revenue, to determine how well the company is positioned to perform in the future. Although Easton Pharmaceutica's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year

Currently Active Assets on Macroaxis

When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:
Check out the analysis of Easton Pharmaceutica Correlation against competitors.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is there potential for Pharmaceuticals market expansion? Will Easton introduce new products? Factors like these will boost the valuation of Easton Pharmaceutica. Projected growth potential of Easton fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.001
Return On Assets
(0.01)
Return On Equity
(0.03)
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Easton Pharmaceutica's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Easton Pharmaceutica should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Easton Pharmaceutica's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.